Company profile for Psyence Biomed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Psyence Biomed Ltd. is a pioneering Nasdaq-listed biopharmaceutical company focused on botanical psychedelics. As the world’s first nature-derived psilocybin biopharma on Nasdaq, we are committed to developing innovative, evidence-based treatments. Led by CEO Dr. Neil Maresky, MD, a renowned R&D leader with experience at AstraZeneca, Wyeth, and Bayer, our physician-driven approach ensures patient-centered solutions. With a t...
Psyence Biomed Ltd. is a pioneering Nasdaq-listed biopharmaceutical company focused on botanical psychedelics. As the world’s first nature-derived psilocybin biopharma on Nasdaq, we are committed to developing innovative, evidence-based treatments. Led by CEO Dr. Neil Maresky, MD, a renowned R&D leader with experience at AstraZeneca, Wyeth, and Bayer, our physician-driven approach ensures patient-centered solutions. With a track record of bringing 50+ medicines to market, Psyence combines “psychedelics” and “science” to transform mental health and wellness through groundbreaking therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/09/3202195/0/en/Psyence-BioMed-CEO-Letter-Highlights-Clinical-Progress-Ethical-Sourcing-of-Ibogaine-Strong-Cash-Position-and-Expanding-Leadership-in-Longevity-Science.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/11/25/3194192/0/en/Psyence-BioMed-Announces-Groundbreaking-Psilocybin-Longevity-Research-Program.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/20/3191764/0/en/Psyence-BioMed-Reaches-Major-Breakthrough-in-Pharmaceutical-Grade-Ibogaine-Supply-for-Worldwide-Clinical-and-Therapeutic-Markets.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186071/0/en/Psyence-BioMed-Establishes-Ibogaine-Operations-in-Africa-Through-Strategic-Investment-in-PsyLabs.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/08/28/3140755/0/en/Psyence-BioMed-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference-September-8-10-2025.html

GLOBENEWSWIRE
28 Aug 2025
Corporate Update, August 2025
Corporate Update, August 2025

04 Aug 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/08/04/3126547/0/en/Corporate-Update-August-2025.html

GLOBENEWSWIRE
04 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty